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 facilitating its interaction with ABCG1 and 
thus allowing increased unloading of cho-
lesterol from lipid-laden macrophages on 
arterial walls. In experimental models, oral 
administration of 4F increased PON1 
activity in the pre-  -HDL fraction, a frac-
tion not normally associated with PON1 
activity, which might explain the protective 
eff ect of this peptide. 4F is less eff ective 
than native ApoA-I in activating LCAT, so 
this specific defect in HDL maturation 
observed in kidney failure is unlikely to be 
reversed by either 4F or other ApoA-I 
mimetic peptides. Th is agent, however, may 
serve as a pharmacologic tool to reverse 
abnormalities in HDL structure that 
accompany renal failure and may perhaps 
serve as a tool to repair vascular injury. 
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 Intrauterine growth retardation, infl u-
enced by the decreased supply of nutrients 
to the human fetus and its environment, 
with resulting low birth weight, was the 
basis of the Brenner hypothesis. This 
hypothesis, which states that low birth 
weight constitutes a risk factor for diseases 
in later life such as systemic arterial hyper-
tension and chronic kidney disease, built 
on the Barker hypothesis, which first 
established a framework for the intrauter-
ine origin of diseases suff ered in adult-
hood. Since the late 1980s and early 1990s, 
when these theories were introduced, 
 signifi cant work has been generated to 
support an inversely related causal link 
between nephron endowment at birth and 
essential hypertension in adult humans, 
supporting the ideas of Barker and Bren-
ner as more than hypotheses. 1 
 For babies born before 36 weeks of 
 gestation, neonatal intensive care units are 
expected to replicate intrauterine develop-
ment. However, many premature infants 
do not demonstrate the expected intrauter-
ine growth at the time of discharge; this has 
resulted in a new term: extrauterine growth 
retardation (EUGR). Clark  et al. defi ne 
EUGR as a growth value  ≤ 10th percentile 
of intrauterine growth expectation based 
on estimated postmenstrual age in prema-
ture neonates (23 – 34 weeks ’ estimated 
gestational age) at the time of discharge 
from the hospital. 2 To date, the notion of 
EUGR as a factor in the development of 
chronic kidney disease or adult-onset sys-
temic arterial hypertension has not been 
fully developed. As nephrogenesis is not 
complete until 36 weeks of  gestation, the 
potential eff ect of EUGR is particularly 
relevant in premature babies. 3 
 In this regard, Bacchetta  et al. 4 (this 
issue) report on the renal function of pre-
mature babies (birth weight   <  1000  g and /
 or   <  30 weeks of gestation) in a 
single-center prospective cohort study. 
Although the authors address measures of 
blood pressure, kidney size, and tubular 
function, as others have done in the past, 
they demonstrate an association between 
EUGR and decreased glomerular fi ltration 
rate (GFR), but within the range of normal 
in childhood. Th ey postulated that this 
moderate decrease in GFR may correspond 
to moderately reduced nephron number, 
which although asymptomatic in child-
hood, may have implications in adulthood. 
Bacchetta  et al. also noted an association 
between decreased protein intake at 7 days 
of life and EUGR in premature babies. 
Their study is novel in that GFR was 
 measured with the use of an exogenous 
marker, inulin, resulting in a more accurate 
assessment of GFR. When prior studies 
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 The Brenner hypothesis postulated that low birth weight and decreased 
nephron number at birth are linked to chronic kidney disease and 
systemic hypertension in adulthood. To date, little is known about the 
effect of extrauterine growth retardation (EUGR) on adult kidney 
disease. Bacchetta  et al. present novel data using inulin to show a 
decrease in renal function for premature children with EUGR. The role of 
protein nutrition and timing in nephrogenesis is discussed. 
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 investigated renal volume and function in 
school-age children born preterm or small 
for gestational age, they estimated renal 
function by calculating GFR using the 
Schwartz formula, and found no diff erence 
between the two groups. 5 Another prob-
lem inherent in prior studies was that they 
often did not distinguish the preterm 
babies into groups based on birth weight. 
 What has been shown clearly is that pre-
natal factors resulting in intrauterine 
growth retardation and low birth weight 
aff ect long-term renal outcomes. Woods 
 et al. have shown with animal models that 
prenatal maternal nutrition is closely tied 
to the window of nephrogenesis, which in 
rats spans a period encompassing the last 
half of gestation and the first half of 
 lactation. 6 Th ey studied Sprague-Dawley 
rats that were fed a protein-restricted diet 
throughout or during the fi rst or second 
half of pregnancy. Th ey found that glomer-
ular number (per kidney) was decreased in 
the offspring of rats protein-restricted 
throughout pregnancy. More specifi cally, 
mean arterial pressures were signifi cantly 
higher in the rats born to mothers protein-
restricted throughout or protein-restricted 
in the second half of pregnancy, rather than 
in rats protein-restricted early in pregnancy 
or those fed a normal diet. Th is evidence 
points to the importance of timing of ade-
quate protein / calorie provision during the 
period of nephrogenesis. Th e reduction in 
nephron number was also more prominent 
in male than in female rats. 6 
 What has not been shown previously 
are the eff ects of EUGR on renal outcomes 
in humans. Rat models are well suited to 
studying the eff ects of EUGR, as the com-
pletion of nephrogenesis occurs 10 days 
after birth. 3 Woods  et al. showed that 
intrarenal renin mRNA, renin concentra-
tion, and immunostaining for renin were 
decreased in animals born to mothers 
restricted in dietary protein. Second, with 
the goal of establishing a causal relation-
ship, they found that blockade of the 
 angiotensin II type 1 receptor during the 
fi rst 12 days of postnatal life resulted in a 
reduced number of glomeruli, reduced 
renal function, and increased arterial pres-
sure in adult animals. In so doing, Woods 
 et al. lent support to the idea that protein 
restriction during pregnancy in rats causes 
suppression of the fetal / newborn renin –
 angiotensin system, which then leads to 
impaired renal development and a 
decreased number of nephrons at birth. 7 
 A second mechanism by which protein 
nutrition may impact nephrogenesis has 
been shown to be mediated by insulin-like 
growth factor-I (IGF-I) and insulin-like 
growth factor-binding protein-I (IGFBP-I). 
IGFBP-I reduces plasma IGF-I bioavaila-
bility. Chin  et al. have reported a positive 
relationship between dietary  protein intake 
and intrarenal IGF-I expression and renal 
growth in rats. 8 Comparative data in rats 
fed isocaloric diets containing variable 
protein content for 1 – 7 days showed that 
rats switched to high-protein diets demon-
strated increased IGF-I and decreased 
IGFBP-I mRNA levels in medullary thick 
ascending limb lengths, whereas those 
switched to low-protein diets exhibited the 
opposite changes in these markers. Th e 
increase in renal IGF-I mRNA closely par-
alleled the signifi cant increases in frac-
tional renal weight, DNA synthesis, and 
medullary thick ascending limb length, 
which then mediates growth in the pres-
ence of adequate protein substrates. Th e 
correlation between changes in renal IGF-I 
expression and changes in renal growth 
argues for a role for locally produced IGF-
I-mediated protein-induced renal growth. 8 
Yeung proposed a unifying hypothesis 
whereby the depressed IGF-I and intrare-
nal renin expression and elevated IGFBP-I 
expression consequent to protein under-
nutrition lead to reduced nephrogenesis 
Late-gestation protein undernutrition
⇓ Renal IGF-I expression
⇓ Renal IGF-I availability
⇓ Sodium and water excretory capacity
Hypertension sensitive to sodium loading
⇓ Kidney renin expression
Oligonephropathy at completion of nephrogenesis
Glomerular loss / ⇓ glomerular filtration area
Glomerular hyperfiltration
Progressive decrease in nephron
number-to-body size ratio later in life 
⇑ Renal IGF-I expression
 Figure 1  |  Depiction of the mechanism of late-gestation protein undernutrition underlying 
the  ‘ nephron numbers hypothesis ’ of developmental programming. IGF-1, insulin-like growth 
factor I; IGFBP-1, insulin-like growth factor-binding protein-I. 
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and oligonephropathy and ultimately con-
tribute to developmental programming for 
late hypertension ( Figure 1 ). 3 
 Th is work by Bacchetta  et al. 4 empha-
sizes the potentially pivotal role of nutri-
tion in the earliest days of extrauterine life. 
Although neonatal intensive care units are 
known to be bastions of attention to detail, 
the study from Japan by Sakurai  et al. 
shows that despite the institution of 
parenteral nutrition and trophic feeding 
as standard nutritional management strat-
egies for very-low-birth-weight infants, 
EUGR continues to be a central problem 
for preterm low-birth-weight infants  ≤ 32 
weeks ’ gestational age. The longer the 
period of time before complete enteral 
feeding was achieved, the greater was the 
risk of EUGR for weight and head cir-
cumference. 9 To maximize the potential 
for nephrogenesis, continued attention 
needs to be devoted in neonatal intensive 
care units to maintaining adequate caloric 
and protein intake in the earliest of post-
natal days. Th is is complicated by confl ict-
ing reports that low-nutrient conditions 
following birth have a positive eff ect on 
adult insulin receptivity. 9 Therefore, a 
dilemma persists between pursuing 
aggressive and pursuing non-aggressive 
degrees of nutrition, with the long-term 
eff ects of aggressive nutrition requiring 
further study. What new strategies can be 
developed to capitalize on the window of 
opportunity of postnatal nephrogenesis? 
 Th e fi ndings of Bacchetta  et al. 4 are pro-
vocative and should stimulate new work 
in the fi eld, as studies with larger numbers 
of premature children in a racially diverse 
ethnic population are needed to validate 
their fi ndings. Th e data would be further 
supported by the determination of GFR 
by inulin clearance in normal-birth-
weight full-term controls. With a larger 
number of children with EUGR, the like-
lihood of a diff erence between males and 
females can also be assessed to determine 
whether female gender aff ords some pro-
tection against the detrimental eff ects of 
postnatal  protein restriction. 
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 Diabetes is recognized as the most com-
mon cause of chronic kidney disease 
worldwide, with the majority of incident 
cases of end-stage renal disease in the 
United States attributed to diabetic neph-
ropathy. The pathogenesis of diabetic 
nephropathy is complex but is largely 
characterized by glomerular fibrosis. 
The predominant histologic lesion is 
glomerular enlargement due to deposition 
of interstitial collagens and a variety of 
other  ‘ scar matrix ’ proteins, which accu-
mulate within the thickened glomerular 
basement membranes in a mesangial pat-
tern and / or as Kimmelstiel-Wilson nod-
ules in the glomerular periphery. 
Interstitial fi brosis, which is composed of 
similar extracellular matrix proteins 
between tubules, is also an important pre-
dictor of diabetic nephro pathy outcomes. 
Mainstay therapies such as glucose and 
blood pressure control can slow diabetic 
nephropathy progression, and some of 
these regimens may be particularly eff ec-
tive because the pharmacologic agents 
 Tissue transglutaminase 
inhibition as treatment for 
diabetic glomerular scarring: 
it ’ s good to be glueless 
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 Diabetic nephropathy is characterized by enhanced glomerular and 
tubulointerstitial deposition of extracellular matrix proteins, which are 
bound together by tissue transglutaminase (TG2). Huang  et al. 
demonstrate that infusion of a novel TG2 inhibitor in diabetic rats 
prevented renal scarring and albuminuria and preserved glomerular 
filtration rate. These studies confirm the role of TG2 in the pathogenesis 
of diabetic nephropathy and add to an emerging literature that 
demonstrates that TG2 is an attractive therapeutic target for sclerosing 
kidney diseases. 
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